Cargando…

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

INTRODUCTION: Breast cancer is a heterogeneous group of tumors, and can be subdivided on the basis of histopathological features, genetic alterations and gene-expression profiles. One well-defined subtype of breast cancer is characterized by a lack of HER2 gene amplification and estrogen and progest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreike, Bas, van Kouwenhove, Marieke, Horlings, Hugo, Weigelt, Britta, Peterse, Hans, Bartelink, Harry, van de Vijver, Marc J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242660/ https://www.ncbi.nlm.nih.gov/pubmed/17910759 http://dx.doi.org/10.1186/bcr1771

Ejemplares similares

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Predicting a local recurrence after breast-conserving therapy by gene expression profiling
por: Nuyten, Dimitry SA, et al.
Publicado: (2006)

Classification of ductal carcinoma in situ by gene expression profiling
por: Hannemann, Juliane, et al.
Publicado: (2006)

Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
por: Tozbikian, Gary, et al.
Publicado: (2014)

Functional characterization of the 19q12 amplicon in grade III breast cancers
por: Natrajan, Rachael, et al.
Publicado: (2012)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
por: Holstege, Henne, et al.
Publicado: (2010)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer
por: Nederlof, Iris, et al.
Publicado: (2021)

The diagnosis and management of pre-invasive breast disease: Pathological diagnosis – problems with existing classifications
por: Van de Vijver, Marc J, et al.
Publicado: (2003)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer
por: Li, Ziyao, et al.
Publicado: (2015)

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
por: Pareja, Fresia, et al.
Publicado: (2016)

Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells
por: Liu, Qiuyu, et al.
Publicado: (2022)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
por: Mackay, Alan, et al.
Publicado: (2011)

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
por: Uva, Paolo, et al.
Publicado: (2018)

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
por: Liu, Gang, et al.
Publicado: (2009)

Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2020)

Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
por: Yao, Qian, et al.
Publicado: (2022)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
por: Olsson, Maxim, et al.
Publicado: (2023)

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
por: Zhao, Hua, et al.
Publicado: (2015)

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
por: She, Qing-Bai, et al.
Publicado: (2016)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues
por: Player, Audrey, et al.
Publicado: (2014)

Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
por: Song, W, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rsikue9cgm7ahm47shog0l22pn